Lexis Nexis
 |    |  
Premier Destination for Sophisticated Buyers of Legal Services

Home > Search Legal Topics > Article Abstract



Martindale-Hubbell Article RSS Feeds Article Feeds

FDA Debarment Powers Possible For Medical Device and Legend Drug Companies


by Karen Weaver
Baker & Hostetler LLP View Firm Credentials
Cleveland Office

September 3, 2008

Previously published on August 21, 2008

The Federal Food, Drug and Cosmetic Act's (FFDCA) voluntary debarment provision applicable to generic drugs is the focus of a bill recently introduced in Congress by Representative Joe Barton, R-Texas, ranking member of the House Energy and Commerce Committee.


 

The views expressed in this article are solely the views of the author and not Martindale-Hubbell. This article is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.




Total Practice Solutions

 
Terms & Conditions | Privacy | Copyright 2008 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.